nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.139	0.251	CbGbCtD
Palonosetron—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.111	0.2	CbGbCtD
Palonosetron—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0728	0.131	CbGbCtD
Palonosetron—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0676	0.122	CbGbCtD
Palonosetron—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0543	0.098	CbGbCtD
Palonosetron—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0311	0.0561	CbGbCtD
Palonosetron—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0305	0.0551	CbGbCtD
Palonosetron—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0285	0.0514	CbGbCtD
Palonosetron—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0194	0.035	CbGbCtD
Palonosetron—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.0129	0.335	CbGeAlD
Palonosetron—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.00984	0.255	CbGeAlD
Palonosetron—HTR3A—nerve—peripheral nervous system neoplasm	0.00504	0.131	CbGeAlD
Palonosetron—HTR3A—ganglion—peripheral nervous system neoplasm	0.00498	0.129	CbGeAlD
Palonosetron—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.00245	0.0634	CbGeAlD
Palonosetron—HTR3A—brainstem—peripheral nervous system neoplasm	0.00216	0.0561	CbGeAlD
Palonosetron—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000796	0.0206	CbGeAlD
Palonosetron—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000477	0.00117	CcSEcCtD
Palonosetron—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000473	0.00116	CcSEcCtD
Palonosetron—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000473	0.00116	CcSEcCtD
Palonosetron—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000471	0.00116	CcSEcCtD
Palonosetron—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000471	0.00116	CcSEcCtD
Palonosetron—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000471	0.00116	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.00116	CcSEcCtD
Palonosetron—Infection—Cisplatin—peripheral nervous system neoplasm	0.000468	0.00115	CcSEcCtD
Palonosetron—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000468	0.00115	CcSEcCtD
Palonosetron—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000464	0.00114	CcSEcCtD
Palonosetron—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000464	0.00114	CcSEcCtD
Palonosetron—Rash—Topotecan—peripheral nervous system neoplasm	0.000464	0.00114	CcSEcCtD
Palonosetron—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000463	0.00114	CcSEcCtD
Palonosetron—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000463	0.00114	CcSEcCtD
Palonosetron—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000462	0.00113	CcSEcCtD
Palonosetron—Headache—Topotecan—peripheral nervous system neoplasm	0.000461	0.00113	CcSEcCtD
Palonosetron—Rash—Tretinoin—peripheral nervous system neoplasm	0.00046	0.00113	CcSEcCtD
Palonosetron—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00046	0.00113	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00046	0.00113	CcSEcCtD
Palonosetron—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00046	0.00113	CcSEcCtD
Palonosetron—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00046	0.00113	CcSEcCtD
Palonosetron—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00046	0.00113	CcSEcCtD
Palonosetron—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000459	0.00113	CcSEcCtD
Palonosetron—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000458	0.00112	CcSEcCtD
Palonosetron—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000458	0.00112	CcSEcCtD
Palonosetron—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000458	0.00112	CcSEcCtD
Palonosetron—Headache—Tretinoin—peripheral nervous system neoplasm	0.000457	0.00112	CcSEcCtD
Palonosetron—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000457	0.00112	CcSEcCtD
Palonosetron—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000457	0.00112	CcSEcCtD
Palonosetron—Constipation—Vincristine—peripheral nervous system neoplasm	0.000456	0.00112	CcSEcCtD
Palonosetron—Pain—Vincristine—peripheral nervous system neoplasm	0.000456	0.00112	CcSEcCtD
Palonosetron—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.00112	CcSEcCtD
Palonosetron—Rash—Melphalan—peripheral nervous system neoplasm	0.000454	0.00111	CcSEcCtD
Palonosetron—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000454	0.00111	CcSEcCtD
Palonosetron—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000452	0.00111	CcSEcCtD
Palonosetron—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00045	0.0011	CcSEcCtD
Palonosetron—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000449	0.0011	CcSEcCtD
Palonosetron—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000448	0.0011	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000447	0.0011	CcSEcCtD
Palonosetron—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000445	0.00109	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000443	0.00109	CcSEcCtD
Palonosetron—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00044	0.00108	CcSEcCtD
Palonosetron—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000439	0.00108	CcSEcCtD
Palonosetron—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.00107	CcSEcCtD
Palonosetron—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.00107	CcSEcCtD
Palonosetron—Nausea—Topotecan—peripheral nervous system neoplasm	0.000437	0.00107	CcSEcCtD
Palonosetron—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000436	0.00107	CcSEcCtD
Palonosetron—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000436	0.00107	CcSEcCtD
Palonosetron—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000433	0.00106	CcSEcCtD
Palonosetron—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000433	0.00106	CcSEcCtD
Palonosetron—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000432	0.00106	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000429	0.00105	CcSEcCtD
Palonosetron—Infection—Etoposide—peripheral nervous system neoplasm	0.000429	0.00105	CcSEcCtD
Palonosetron—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000428	0.00105	CcSEcCtD
Palonosetron—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000428	0.00105	CcSEcCtD
Palonosetron—Nausea—Melphalan—peripheral nervous system neoplasm	0.000428	0.00105	CcSEcCtD
Palonosetron—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000423	0.00104	CcSEcCtD
Palonosetron—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000421	0.00103	CcSEcCtD
Palonosetron—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000421	0.00103	CcSEcCtD
Palonosetron—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000421	0.00103	CcSEcCtD
Palonosetron—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00042	0.00103	CcSEcCtD
Palonosetron—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000419	0.00103	CcSEcCtD
Palonosetron—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.00102	CcSEcCtD
Palonosetron—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.00102	CcSEcCtD
Palonosetron—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000411	0.00101	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.00101	CcSEcCtD
Palonosetron—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00101	CcSEcCtD
Palonosetron—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000408	0.001	CcSEcCtD
Palonosetron—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.001	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000407	0.000999	CcSEcCtD
Palonosetron—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000403	0.00099	CcSEcCtD
Palonosetron—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.00099	CcSEcCtD
Palonosetron—Pain—Cisplatin—peripheral nervous system neoplasm	0.000403	0.000989	CcSEcCtD
Palonosetron—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.000974	CcSEcCtD
Palonosetron—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000973	CcSEcCtD
Palonosetron—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000393	0.000964	CcSEcCtD
Palonosetron—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000392	0.0102	CbGeAlD
Palonosetron—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000391	0.00096	CcSEcCtD
Palonosetron—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000388	0.000951	CcSEcCtD
Palonosetron—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000385	0.000945	CcSEcCtD
Palonosetron—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000942	CcSEcCtD
Palonosetron—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000384	0.000942	CcSEcCtD
Palonosetron—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000382	0.000939	CcSEcCtD
Palonosetron—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000379	0.000931	CcSEcCtD
Palonosetron—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.000929	CcSEcCtD
Palonosetron—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000376	0.000923	CcSEcCtD
Palonosetron—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000375	0.000921	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000373	0.000915	CcSEcCtD
Palonosetron—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000372	0.000914	CcSEcCtD
Palonosetron—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000372	0.000914	CcSEcCtD
Palonosetron—Constipation—Etoposide—peripheral nervous system neoplasm	0.000369	0.000906	CcSEcCtD
Palonosetron—Pain—Etoposide—peripheral nervous system neoplasm	0.000369	0.000906	CcSEcCtD
Palonosetron—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000366	0.000898	CcSEcCtD
Palonosetron—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000365	0.000895	CcSEcCtD
Palonosetron—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000881	CcSEcCtD
Palonosetron—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000878	CcSEcCtD
Palonosetron—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000874	CcSEcCtD
Palonosetron—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000872	CcSEcCtD
Palonosetron—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000354	0.00087	CcSEcCtD
Palonosetron—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000353	0.000866	CcSEcCtD
Palonosetron—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000352	0.000865	CcSEcCtD
Palonosetron—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000352	0.000863	CcSEcCtD
Palonosetron—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.000856	CcSEcCtD
Palonosetron—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.000855	CcSEcCtD
Palonosetron—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000347	0.000852	CcSEcCtD
Palonosetron—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000851	CcSEcCtD
Palonosetron—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.00085	CcSEcCtD
Palonosetron—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000341	0.000838	CcSEcCtD
Palonosetron—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000341	0.000838	CcSEcCtD
Palonosetron—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000339	0.000832	CcSEcCtD
Palonosetron—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000338	0.00083	CcSEcCtD
Palonosetron—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000826	CcSEcCtD
Palonosetron—Rash—Vincristine—peripheral nervous system neoplasm	0.000336	0.000825	CcSEcCtD
Palonosetron—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000336	0.000824	CcSEcCtD
Palonosetron—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000822	CcSEcCtD
Palonosetron—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000334	0.00082	CcSEcCtD
Palonosetron—Headache—Vincristine—peripheral nervous system neoplasm	0.000334	0.000819	CcSEcCtD
Palonosetron—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000815	CcSEcCtD
Palonosetron—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000813	CcSEcCtD
Palonosetron—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000808	CcSEcCtD
Palonosetron—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000328	0.000806	CcSEcCtD
Palonosetron—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000322	0.000791	CcSEcCtD
Palonosetron—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000788	CcSEcCtD
Palonosetron—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000781	CcSEcCtD
Palonosetron—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000318	0.000781	CcSEcCtD
Palonosetron—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000779	CcSEcCtD
Palonosetron—Nausea—Vincristine—peripheral nervous system neoplasm	0.000317	0.000777	CcSEcCtD
Palonosetron—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000776	CcSEcCtD
Palonosetron—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000764	CcSEcCtD
Palonosetron—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00031	0.00076	CcSEcCtD
Palonosetron—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00076	CcSEcCtD
Palonosetron—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000759	CcSEcCtD
Palonosetron—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000758	CcSEcCtD
Palonosetron—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000755	CcSEcCtD
Palonosetron—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000753	CcSEcCtD
Palonosetron—Chills—Epirubicin—peripheral nervous system neoplasm	0.000306	0.00075	CcSEcCtD
Palonosetron—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000305	0.00075	CcSEcCtD
Palonosetron—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000747	CcSEcCtD
Palonosetron—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000739	CcSEcCtD
Palonosetron—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0003	0.000735	CcSEcCtD
Palonosetron—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000732	CcSEcCtD
Palonosetron—Rash—Cisplatin—peripheral nervous system neoplasm	0.000297	0.000729	CcSEcCtD
Palonosetron—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000297	0.000729	CcSEcCtD
Palonosetron—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000728	CcSEcCtD
Palonosetron—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000728	CcSEcCtD
Palonosetron—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000295	0.000725	CcSEcCtD
Palonosetron—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000723	CcSEcCtD
Palonosetron—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000721	CcSEcCtD
Palonosetron—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000718	CcSEcCtD
Palonosetron—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000717	CcSEcCtD
Palonosetron—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000713	CcSEcCtD
Palonosetron—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000702	CcSEcCtD
Palonosetron—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000285	0.000701	CcSEcCtD
Palonosetron—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000699	CcSEcCtD
Palonosetron—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000697	CcSEcCtD
Palonosetron—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000694	CcSEcCtD
Palonosetron—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000691	CcSEcCtD
Palonosetron—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00028	0.000687	CcSEcCtD
Palonosetron—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000684	CcSEcCtD
Palonosetron—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000678	CcSEcCtD
Palonosetron—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000274	0.000674	CcSEcCtD
Palonosetron—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000673	CcSEcCtD
Palonosetron—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000673	CcSEcCtD
Palonosetron—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000673	CcSEcCtD
Palonosetron—Rash—Etoposide—peripheral nervous system neoplasm	0.000272	0.000668	CcSEcCtD
Palonosetron—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000272	0.000667	CcSEcCtD
Palonosetron—Headache—Etoposide—peripheral nervous system neoplasm	0.00027	0.000664	CcSEcCtD
Palonosetron—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000664	CcSEcCtD
Palonosetron—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000659	CcSEcCtD
Palonosetron—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000631	CcSEcCtD
Palonosetron—Nausea—Etoposide—peripheral nervous system neoplasm	0.000256	0.000629	CcSEcCtD
Palonosetron—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000628	CcSEcCtD
Palonosetron—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000622	CcSEcCtD
Palonosetron—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000252	0.00062	CcSEcCtD
Palonosetron—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000252	0.00062	CcSEcCtD
Palonosetron—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000617	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000615	CcSEcCtD
Palonosetron—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000612	CcSEcCtD
Palonosetron—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000606	CcSEcCtD
Palonosetron—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000594	CcSEcCtD
Palonosetron—Infection—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00059	CcSEcCtD
Palonosetron—Shock—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000584	CcSEcCtD
Palonosetron—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000583	CcSEcCtD
Palonosetron—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000582	CcSEcCtD
Palonosetron—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000581	CcSEcCtD
Palonosetron—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00058	CcSEcCtD
Palonosetron—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000577	CcSEcCtD
Palonosetron—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000573	CcSEcCtD
Palonosetron—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000573	CcSEcCtD
Palonosetron—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000571	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000569	CcSEcCtD
Palonosetron—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000566	CcSEcCtD
Palonosetron—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000566	CcSEcCtD
Palonosetron—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000561	CcSEcCtD
Palonosetron—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000555	CcSEcCtD
Palonosetron—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00055	CcSEcCtD
Palonosetron—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000546	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000541	CcSEcCtD
Palonosetron—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000541	CcSEcCtD
Palonosetron—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000539	CcSEcCtD
Palonosetron—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000537	CcSEcCtD
Palonosetron—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000536	CcSEcCtD
Palonosetron—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000534	CcSEcCtD
Palonosetron—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000533	CcSEcCtD
Palonosetron—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00053	CcSEcCtD
Palonosetron—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000528	CcSEcCtD
Palonosetron—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000524	CcSEcCtD
Palonosetron—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000523	CcSEcCtD
Palonosetron—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000516	CcSEcCtD
Palonosetron—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000514	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000513	CcSEcCtD
Palonosetron—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000512	CcSEcCtD
Palonosetron—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000508	CcSEcCtD
Palonosetron—Pain—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000508	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000501	CcSEcCtD
Palonosetron—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000497	CcSEcCtD
Palonosetron—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000494	CcSEcCtD
Palonosetron—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00049	CcSEcCtD
Palonosetron—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000489	CcSEcCtD
Palonosetron—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000486	CcSEcCtD
Palonosetron—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000484	CcSEcCtD
Palonosetron—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000478	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000474	CcSEcCtD
Palonosetron—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000474	CcSEcCtD
Palonosetron—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00047	CcSEcCtD
Palonosetron—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00047	CcSEcCtD
Palonosetron—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00047	CcSEcCtD
Palonosetron—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00047	CcSEcCtD
Palonosetron—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000449	CcSEcCtD
Palonosetron—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000438	CcSEcCtD
Palonosetron—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000434	CcSEcCtD
Palonosetron—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000434	CcSEcCtD
Palonosetron—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000426	CcSEcCtD
Palonosetron—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00042	CcSEcCtD
Palonosetron—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000406	CcSEcCtD
Palonosetron—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000405	CcSEcCtD
Palonosetron—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000394	CcSEcCtD
Palonosetron—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000393	CcSEcCtD
Palonosetron—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000389	CcSEcCtD
Palonosetron—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000378	CcSEcCtD
Palonosetron—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000376	CcSEcCtD
Palonosetron—Rash—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000375	CcSEcCtD
Palonosetron—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000374	CcSEcCtD
Palonosetron—Headache—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000372	CcSEcCtD
Palonosetron—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000363	CcSEcCtD
Palonosetron—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000353	CcSEcCtD
Palonosetron—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000349	CcSEcCtD
Palonosetron—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000347	CcSEcCtD
Palonosetron—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000346	CcSEcCtD
Palonosetron—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000344	CcSEcCtD
Palonosetron—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000326	CcSEcCtD
